Morepen Labs rises 4% after China approves anti-allergy API export
The company commands an over 80 per cent market share in the US generics market for Loratadine, according to its filing ...
Washington Technology6d
Leidos fights for another chance at $89B national biomedical lab contract
The company has supported the only federally-funded research and development center focused on medical research for 17 years, ...
CNBCTV182d
Morepen Labs shares rise on China export approval for allergy drug
Loratadine, a widely prescribed second-generation antihistamine, is commonly used to treat allergic conditions such as hay ...
Morepen Lab gains after receiving Loratadine approval for export to China
Morepen Laboratories advanced 2.22% to Rs 48.91 after the company announced that it has received approval from the Center for Drug Evaluation (CDE) of the National Medical Products Administration ...